Stay updated on Comparing DTG vs. SOC in Children with HIV: Clinical Trial
Sign up to get notified when there's something new on the Comparing DTG vs. SOC in Children with HIV: Clinical Trial page.

Latest updates to the Comparing DTG vs. SOC in Children with HIV: Clinical Trial page
- Check5 days agoChange DetectedThe ODYSSEY (PENTA 20) record is now available, with details on the trial of dolutegravir-based treatment versus standard care for children with HIV, along with study results, publications, and supporting documents.SummaryDifference75%

- Check12 days agoChange DetectedThe site footer now shows revision v3.8.0 instead of v3.7.2. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check19 days agoChange DetectedA site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision indicator changes from v3.7.1 to v3.7.2, while the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check54 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, preventing viewing of the study details and results. This indicates a site access issue rather than an update to the study content.SummaryDifference20%

Stay in the know with updates to Comparing DTG vs. SOC in Children with HIV: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing DTG vs. SOC in Children with HIV: Clinical Trial page.